Kaplan–Meier survival analysis of 367 melanoma patients with low (n = 282) or high (n = 85) expression of SETD6 revealed that a high level of SETD6 correlates with poor patient prognosis (Fig. 1A). This evidence concerns the gene SETD6 and melanoma.